Health Care • Biotechnology: Laboratory Analytical Instruments
$174.87 ▼ -6.28
(-3.47%)
MKT CAP: $49.30B • VOL: 2.76M
52W L $108 52W H $183
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$147
MEDIAN
$196
MEAN
$199
HIGH
$238
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE A TAPE
A // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $211.59 | $201.10 | 2025-02-14 | $159.13 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $220.34 | $206.35 | 2025-02-06 | $164.38 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $199.35 | $192.36 | 2025-01-29 | $167.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $178.37 | — | 2025-01-17 | $171.37 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $153.89 | $166.13 | 2025-01-09 | $155.63 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $208.10 | $181.86 | 2024-12-18 | $152.14 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $169.62 | $176.62 | 2024-12-04 | $162.63 | -4.3% | 48% | C |